Announcements

Dr Brown appointed to Advisory Board
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Share Option Scheme
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announces that the Company has adopted the Sativa Investments PLC Share Plan (the “Scheme”), to recognise the work accomplished by the Sativa team
Option agreement on 298,806 sq ft glasshouse signed
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has now signed the option agreement to lease a 7.53 acre site for medicinal cannabis production in Wiltshire on which the Company intends to…
Change in Board responsibilities
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announces that Mark Blower, currently an Executive Director of the Company, is moving to a non-Executive Director role with immediate effect.
Heads of Terms for an option to lease a 7.53 acre UK site for medicinal cannabis production
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has signed Heads of Terms for an £85K option to lease a 7.53 acre development site in Wiltshire.
Sativa Investments Share Placing
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is pleased to announce that it has raised £3.75 million (before expenses) by way of a placing of 62,500,000 new ordinary shares of 0.25p…
Sativa Half Year Financial Results (Unaudited) June 2018
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is pleased to announce its half year results for the six months ended 30 June 2018.
Medicinal cannabis group Sativa enters joint venture with Lexamed GmbH
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has established a joint venture with German-based Lexamed GmbH (“Lexamed”), forming a new German medicinal cannabis company named Sativa Germany GmbH
Sativa appoints Chief Financial Officer and Director
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has appointed Joseph Colliver FCA as Chief Financial Officer and a Director of the Company.
Directors’ appointments/resignation
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has appointed Jonathan Peter Wearing as an independent non-executive director and Angus Jeremy Kerr as a non-executive director of the Company.
Sativa signs IP agreement with Canadian-based Veritas Pharma Inc.
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has signed an IP sharing agreement with Canadian-based emerging global pharmaceutical company Veritas Pharma Inc. (“Veritas” or “Veritas Pharma”) in which the Company invested…
Sativa agrees to the 100% purchase of PhytoVista Laboratories
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has agreed to purchase, for £435,000, 100 per cent of PhytoVista Laboratories (“PhytoVista”), a UK-based laboratory that tests CBD oils and hemp products.
Dealing Arrangements
The Board of Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is aware of the exceptional and growing demand amongst investors to own shares in the Company. As announced on the Company’s…
Share Placing completed to Miton Asset Management
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that the share Placing of 12,500,000 new Ordinary Shares at a subscription price of 4 pence per share announced on Wednesday 27 June, raising…
Orderly Market Agreement - Director’s Dealing
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that today, 25 June 2018, Mark Blower, an executive director of the Company, sold 1,000,000 ordinary shares of £0.0025 at a price of £0.04…
Sativa Foundation to fund academic research in to medicinal cannabis
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has formed the Sativa Foundation (“The Foundation”) to fund academic research into medicinal cannabis and its benefits to the pharmaceutical and healthcare sectors.
Sativa agrees purchase of 100% of CBD product provider George Botanicals
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has agreed to purchase, for £415,000, 100 per cent of George Botanicals Ltd, a UK-based manufacturer, wholesaler and distributor of wellness CBD products, following the…
Sativa passes resolution at General Meeting to broaden investment policy
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, announces that all Resolutions were passed by the requisite majority at the Company’s General Meeting today, including Resolutions to broaden its investment strategy beyond Canada,…
Sativa Share Price Movement
The Board of Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, notes the recent rise in the Company’s share price. Whilst the Company has made investments to date, it is unaware of any…
Sativa appoints pharmacologist Sir Alasdair Breckenridge to its Advisory Board
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has appointed Sir Alasdair Breckenridge to its Advisory Board, whose medical career as a pharmacologist totals close to 60 years.
SATI Sativa Investments PLC broadens investment strategy
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, is seeking shareholder approval to broaden its investment policy beyond Canada and has today notified shareholders of a General Meeting to be held on 22…